ArticleBiochemical and biophysical research communications2021

Novel HIV PR inhibitors with C4-substituted bis-THF and bis-fluoro-benzyl target the two active site mutations of highly drug resistant mutant PR

Johnson Agniswamy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.